MXCT
MaxCyte Inc
1.20$
-4.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 80.4% | 70.9% | 69.3% | 69.8% | 69.5% | 71.7% | 67.7% | 65.2% | 58.4% | 58.5% | 63.2% | 65.7% | |
| 18.4% | 17.3% | 8.6% | 14.9% | 14.9% | 11.6% | 10.2% | 6.9% | 6.1% | 9.9% | 7.5% | 8.1% | |
| 71.3% | 62.7% | 61.1% | 62.6% | 61.9% | 64.5% | 60.1% | 57.6% | 49.5% | 50.9% | 7.5% | 57.2% | |
| 3.1% | 2.2% | 2.3% | 1.8% | 1.8% | 2.0% | 2.4% | 2.6% | 3.9% | 1.7% | 2.2% | 2.1% | |
| 4.7% | 4.6% | 4.6% | 4.4% | 4.2% | 3.7% | 3.6% | 3.6% | 3.6% | 3.7% | 3.9% | 4.2% | |
| – | – | – | – | – | – | 1.7% | 1.7% | 1.7% | – | – | – | |
| – | – | – | – | – | – | 0.2% | 0.3% | 0.3% | 0.3% | 0.4% | 0.4% | |
| 12.5% | 13.5% | 12.2% | 12.0% | 14.2% | 13.9% | 13.3% | 13.2% | 15.6% | 15.3% | 13.7% | 14.0% | |
| 6.2% | 6.7% | 5.2% | 4.9% | 7.1% | 6.6% | 5.5% | 5.3% | 7.5% | 7.0% | 5.3% | 5.4% | |
| 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.4% | 0.6% | 0.6% | 0.6% | 0.7% | 0.7% | 0.8% | |
| 0.2% | 0.3% | 0.6% | 0.4% | 0.8% | 0.6% | 1.0% | 0.6% | 0.6% | 0.7% | 0.6% | 0.9% | |
| 87.5% | 86.5% | 87.8% | 88.0% | 85.8% | 86.1% | 86.7% | 86.8% | 84.4% | 84.7% | 86.3% | 86.0% | |
| -63.9% | -65.5% | -71.9% | -77.4% | -83.0% | -90.6% | -98.8% | -109.0% | -118.0% | -129.1% | -136.9% | -149.0% | |
| 38.8% | 38.7% | 40.4% | 41.6% | 42.3% | 43.8% | 46.1% | 48.4% | 49.8% | 52.6% | 55.0% | 57.8% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.